Dagadas, Reah .
HRN: 25-14-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2024
METRONIDAZOLE 500MG (TAB)
05/25/2024
05/31/2024
PO
500mg
TID
Thickly Msaf
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes